Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the fourth most frequent cause of cancer-related death worldwide. HCC frequently presents as advanced disease at diagnosis, and disease relapse following radical surgery is frequent. In recent years, immune checkpoint inhibitors (ICIs) have revolutionized the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Carloni, Riccardo, Sabbioni, Simone, Rizzo, Alessandro, Ricci, Angela Dalia, Palloni, Andrea, Petrarota, Cataldo, Cusmai, Antonio, Tavolari, Simona, Gadaleta-Caldarola, Gennaro, Brandi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493094/
https://www.ncbi.nlm.nih.gov/pubmed/37701562
http://dx.doi.org/10.2147/JHC.S390963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493094/
https://www.ncbi.nlm.nih.gov/pubmed/37701562
http://dx.doi.org/10.2147/JHC.S390963

Ejemplares similares